Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure with Reduced Ejection Fraction (HFrEF), and the Risk of ESKD in Type 2 Diabetes (T2D)

被引:0
|
作者
Kim, David [1 ]
Sarwal, Amara [1 ,2 ]
Wei, Guo [1 ,2 ]
Boucher, Robert E. [1 ,2 ]
Singh, Ravinder [1 ,2 ]
Hartsell, Sydney Elizabeth [1 ,2 ]
Drakos, Stavros [1 ,2 ]
Beddhu, Srinivasan [1 ,2 ]
机构
[1] Univ Utah Hlth, Salt Lake City, UT USA
[2] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
来源
关键词
D O I
10.1681/ASN.2024e5hcsja9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-PO357
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Is there a difference in precipitants between heart failure with preserved ejection fraction (HFPEF) and heart failure with reduced ejection fraction (HFREF)?
    Ali, S. M.
    Easton, K.
    Peck, K. Y.
    Hare, J.
    Kaye, D.
    Parikh, S.
    Hopper, I.
    AUSTRALASIAN JOURNAL ON AGEING, 2018, 37 : 37 - 38
  • [2] Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
    Chen, Yei-Tsung
    Wong, Lee Lee
    Liew, Oi Wah
    Richards, Arthur Mark
    CELLS, 2019, 8 (12)
  • [3] Carvedilol Improves Clinical Outcomes in Heart Failure With Preserved Ejection Fraction (HFpEF) as Well as Reduced Ejection Fraction (HFrEF)
    Kato, Naoko
    Kinugawa, Koichiro
    Kazuma, Keiko
    Yao, Atsushi
    Hatano, Masaru
    Shiga, Taro
    Hirata, Yasunobu
    Nagai, Ryozo
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : S172 - S172
  • [4] Heart failure with preserved ejection fraction (HFpEF)
    Maeder, Micha T.
    Buser, Marc
    Brenner, Roman
    Rickli, Hans
    THERAPEUTISCHE UMSCHAU, 2018, 75 (03) : 161 - 169
  • [5] Poor Adherence to Medication is an Independent Risk Factor for Adverse Clinical Outcomes in Heart Failure with Reduced Ejection Fraction (HFrEF) but not Heart Failure with Preserved Ejection Fraction (HFpEF)
    Kato, Naoko
    Kinugawa, Koichiro
    Nakayama, Etsuko
    Tsuji, Takako
    Kumagai, Yumiko
    Miura, Chikako
    Nagayama, Masayoshi
    Sumiyoshi, Tetsuya
    Tomoike, Hitonobu
    Nagai, Ryozo
    CIRCULATION, 2012, 126 (21)
  • [6] Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF)
    Sobue, Yoshihiro
    Watanabe, Eiichi
    Lip, Gregory Y. H.
    Koshikawa, Masayuki
    Ichikawa, Tomohide
    Kawai, Mayumi
    Harada, Masahide
    Inamasu, Joji
    Ozaki, Yukio
    HEART AND VESSELS, 2018, 33 (04) : 403 - 412
  • [7] Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF)
    Yoshihiro Sobue
    Eiichi Watanabe
    Gregory Y. H. Lip
    Masayuki Koshikawa
    Tomohide Ichikawa
    Mayumi Kawai
    Masahide Harada
    Joji Inamasu
    Yukio Ozaki
    Heart and Vessels, 2018, 33 : 403 - 412
  • [8] Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?
    Ohte, Nobuyuki
    Little, William C.
    CIRCULATION JOURNAL, 2015, 79 (03) : 508 - 509
  • [9] Heart peptides and HFpEF (heart failure with preserved ejection fraction)
    Takahashi, Kazuhiro
    PEPTIDES, 2022, 157
  • [10] PREDICTORS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
    Kumar, A.
    Saluja, A. K.
    Khan, A.
    Gandhi, D.
    Morsy, M. A.
    Khalife, W. I.
    CARDIOLOGY, 2014, 128 : 467 - 468